Neon Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 71

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $70.6M

Neon Therapeutics General Information

Description

Developer of neoantigen-targeted therapies designed to treat cancer by directing the immune system towards neoantigens. The company specializes in identifying patient-derived tumor-specific neoantigens to create individualized vaccines and autologous T-cell therapies, thereby enabling targeted treatment approaches that harness the immune system to fight cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 40 Erie Street
  • Suite 110
  • Cambridge, MA 02139
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 40 Erie Street
  • Suite 110
  • Cambridge, MA 02139
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2020 $70.6M Completed Generating Revenue
3. IPO 27-Jun-2018 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Dec-2017 $106M $161M Completed Startup
1. Early Stage VC (Series A) 01-Oct-2015 $55M $55M Completed Startup
To view Neon Therapeutics’s complete valuation and funding history, request access »

Neon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Neon Therapeutics’s complete cap table history, request access »

Neon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neoantigen-targeted therapies designed to treat cancer by directing the immune system towards neoantigens.
Drug Discovery
Cambridge, MA
71 As of 2019

Flemington, NJ
 

Houston, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neon Therapeutics Competitors (49)

One of Neon Therapeutics’s 49 competitors is Arno Therapeutics, a Formerly VC-backed company based in Flemington, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arno Therapeutics Formerly VC-backed Flemington, NJ
OncoResponse Venture Capital-Backed Houston, TX
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Cellaion Formerly VC-backed Mont-Saint-Guibert, Belgium
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
You’re viewing 5 of 49 competitors. Get the full list »

Neon Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neon Therapeutics Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Access Industries PE/Buyout Minority
ArrowMark Partners Asset Manager Minority
Casdin Capital Venture Capital Minority
Clal Biotechnology Industries Venture Capital Minority
Fidelity Management & Research Company Asset Manager Minority
You’re viewing 5 of 13 investors. Get the full list »

Neon Therapeutics ESG

Risk Overview

Risk Rating

Updated January, 31, 2026

22.15 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Pharmaceuticals

Industry

of 952

Rank

Percentile

Biotechnology

Subindustry

of 444

Rank

Percentile

To view Neon Therapeutics’s complete esg history, request access »

Neon Therapeutics FAQs

  • When was Neon Therapeutics founded?

    Neon Therapeutics was founded in 2013.

  • Where is Neon Therapeutics headquartered?

    Neon Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Neon Therapeutics?

    Neon Therapeutics has 71 total employees.

  • What industry is Neon Therapeutics in?

    Neon Therapeutics’s primary industry is Drug Discovery.

  • Is Neon Therapeutics a private or public company?

    Neon Therapeutics is a Private company.

  • What is the current valuation of Neon Therapeutics?

    The current valuation of Neon Therapeutics is .

  • What is Neon Therapeutics’s current revenue?

    The current revenue for Neon Therapeutics is .

  • How much funding has Neon Therapeutics raised over time?

    Neon Therapeutics has raised $261M.

  • Who are Neon Therapeutics’s investors?

    Access Industries, ArrowMark Partners, Casdin Capital, Clal Biotechnology Industries, and Fidelity Management & Research Company are 5 of 13 investors who have invested in Neon Therapeutics.

  • Who are Neon Therapeutics’s competitors?

    Arno Therapeutics, OncoResponse, Inovio Pharmaceuticals, Cellaion, and NGM Biopharmaceuticals are some of the 49 competitors of Neon Therapeutics.

  • When was Neon Therapeutics acquired?

    Neon Therapeutics was acquired on 06-May-2020.

  • Who acquired Neon Therapeutics?

    Neon Therapeutics was acquired by BioNTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process